Unisys Corp. (UIS) Jumps 12.4% on January 29

Equities Staff |

Unisys Corp. (UIS) was among the biggest gainers on the Russell 2000 for Friday January 29 as the stock popped 12.4% to $10.02, representing a gain of $1.105 per share. Some 1.14 million shares traded hands on 7,888 trades, compared with an average daily volume of 451,557 shares out of a total float of 49.93 million. The stock opened at $9.54 and traded with an intraday range of $11.30 to $9.54.

After today's gains, Unisys Corp. reached a market cap of $500.09 million. Unisys Corp. has had a trading range between $25.64 and $8.15 over the last year, and it had a 50-day SMA of $11.02 and a 200-day SMA of $15.55.

Unisys Corp is an information technology company. It offers outsourcing & managed services, systems integration & consulting services, high-end server technology, cybersecurity & cloud management software, & maintenance & infrastructure support services.

Unisys Corp. is based out of Blue Bell, PA and has some 23,200 employees. Its CEO is Peter A. Altabef.

For a complete fundamental analysis analysis of Unisys Corp., check out Equities.com’s Stock Valuation Analysis report for UIS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.